Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PHAT
PHAT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PHAT News
Barclays Upgrades Phathom to Overweight Amid Sales Recovery Prospects
3d ago
seekingalpha
PHATHOM PHARMACEUTICALS INC.: BARCLAYS INCREASES TARGET PRICE FROM $16 TO $18
4d ago
moomoo
Surge in Options Trading Volume for Adobe and Phathom Pharmaceuticals
Mar 19 2026
NASDAQ.COM
Emerging Trends in H. pylori Infection Market
Mar 04 2026
Newsfilter
Phathom Pharmaceuticals Q4 2025 Earnings Call Highlights
Feb 26 2026
seekingalpha
Phathom Pharmaceuticals Set to Announce Q4 Earnings
Feb 25 2026
seekingalpha
Phathom Pharmaceuticals Sees Q4 Sales of $57-58M, Prices $130M Public Offering
Jan 08 2026
Benzinga
Northrop Grumman Shares Rise 6.84% Following Military Budget Proposal
Jan 08 2026
Benzinga
AZZ Inc Reports Q3 Earnings Beat, Shares Rise 2.1%
Jan 08 2026
Benzinga
Phathom Pharmaceuticals Prices 6.875M Share Offering at $16, Raising $130M
Jan 08 2026
Globenewswire
Phathom Pharmaceuticals Plans Public Offering to Fund R&D
Jan 07 2026
Globenewswire
GH Research (GHRS) Stock Surges 22.36% Ahead of Key Update
Jan 05 2026
NASDAQ.COM
Unexpected 12-Month Forecast for ITOT by Analyst
Nov 12 2025
NASDAQ.COM
Phathom anticipates $1B opportunity in GI market as sales restructuring boosts revenue by 25%
Oct 30 2025
SeekingAlpha
Phathom Pharmaceuticals surpasses revenue and earnings expectations; revises FY25 forecast
Oct 30 2025
SeekingAlpha
Significant Options Activity on Wednesday: U, FSLY, PHAT
Oct 15 2025
NASDAQ.COM
Show More News
